Structural dissection of 13-epiestrones based on the interaction with human Organic anion-transporting polypeptide, OATP2B1. Issue 200 (June 2020)

• Record Type: Journal Article
• Authors: Laczkó-Rigó, Réka; Jójárt, Rebeka; Mernyák, Erzsébet; Bakos, Éva; Tuerkova, Alzbeta; Zdrazil, Barbara; Özvegy-Laczka, Csilla
• Is Part Of: Journal of steroid biochemistry and molecular biology. Issue 200(2020)
• Publication Date: 2020-06
• Subjects: OATP Organic anion-transporting polypeptide -- E1S estrone-3-sulfate -- HSD17ß1 17ß-hydroxysteroid-dehydrogenase type 1 -- SAR structure activity relationship -- STS steroid sulfatase; Organic anion-transporting polypeptide -- 13-epiestrones -- Inhibitor -- SAR; Steroid hormones -- Periodicals; Biochemistry -- Periodicals; Hormones -- Periodicals; Molecular Biology -- Periodicals; Hormones stéroïdes -- Périodiques; Steroid hormones; Periodicals; 572.579
• DOI: 10.1016/j.jsbmb.2020.105652
• Languages: English
• ISSNs: 0960-0760

Abstract

Highlights: OATP2B1 inhibitory effect of C-2/4 modified 13-epiestrones was investigated. Potent 13-epiestrone-based inhibitors of OATP2B1 were identified. SAR analysis defined structural elements important for OATP2B1 inhibition. Our results help to understand the drug/inhibitor interaction profile of OATP2B1. The novel inhibitors represent a new tool to block steroid hormone entry into tumors. Abstract: Human OATP2B1 encoded by the SLCO2B1 gene is a multispecific transporter mediating the cellular uptake of large, organic molecules, including hormones, prostaglandins and bile acids. OATP2B1 is ubiquitously expressed in the human body, with highest expression levels in pharmacologically relevant barriers, like enterocytes, hepatocytes and endothelial cells of the blood-brain-barrier. In addition to its endogenous substrates, OATP2B1 also recognizes clinically applied drugs, such as statins, antivirals, antihistamines and chemotherapeutic agents and influences their pharmacokinetics. On the other hand, OATP2B1 is also overexpressed in various tumors. Considering that elevated hormone uptake by OATP2B1 results in increased cell proliferation of hormone dependent tumors (e.g. breast or prostate), inhibition of OATP2B1 can be a good strategy to inhibit the growth of these tumors. 13-epiestrones represent a potential novel strategy in the treatment of hormone dependent cancers by the suppression of local estrogen production due to the inhibition of the key enzyme of estrone metabolism, 17ß-hydroxysteroid-dehydrogenase type 1 (HSD17ß1). Recently, we have demonstrated that various phosphonated 13-epiestrones are dual inhibitors also suppressing OATP2B1 function. In order to gain better insights into the molecular determinants of OATP2B1 13-epiestrone interaction we investigated the effect of C-2 and C-4 halogen or phenylalkynyl modified epiestrones on OATP2B1 transport function. Potent inhibitors (with EC50 values in the low micromolar range) as well as non-inhibitors of OATP2B1 function were identified. Based on the structure-activity relationship (SAR) of the various 13-epiestrone derivatives we could define structural elements important for OATP2B1 inhibition. Our results may help to understand the drug/inhibitor interaction profile of OATP2B1, and also may be a useful strategy to block steroid hormone entry into tumors.